📰 Vstm News
Vstm News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Vstm. Real-time updates on events, politics, business and more.
May 6, 2024
Verastem, Inc. (NASDAQ:VSTM – Get Free Report) has been given a consensus rating of “Buy” by the seven ratings firms that are covering the firm, Marketbeat reports. Seven equities research analysts have rated the stock with a buy rating. The average 1-year price target among analysts that have covered the stock in the last year […]
May 4, 2024
Shares of Verastem, Inc. (NASDAQ:VSTM – Get Free Report) have received a consensus recommendation of “Buy” from the seven analysts that are currently covering the stock, MarketBeat Ratings reports. Seven investment analysts have rated the stock with a buy rating. The average 12-month price objective among brokerages that have updated their coverage on the stock […]
May 4, 2024
Verastem, Inc. (NASDAQ:VSTM – Get Free Report) has been given an average recommendation of “Buy” by the seven ratings firms that are covering the firm, Marketbeat.com reports. Seven analysts have rated the stock with a buy recommendation. The average 12 month target price among analysts that have issued a report on the stock in the […]
February 21, 2024
Verastem, Inc. (NASDAQ:VSTM – Get Free Report) has been assigned a consensus rating of “Buy” from the seven research firms that are currently covering the company, Marketbeat Ratings reports. Seven analysts have rated the stock with a buy rating. The average twelve-month target price among analysts that have covered the stock in the last year […]
January 25, 2024
Shares of Verastem, Inc. (NASDAQ:VSTM – Get Free Report) have been given an average recommendation of “Buy” by the seven research firms that are currently covering the stock, Marketbeat.com reports. Seven research analysts have rated the stock with a buy rating. The average 1-year price objective among analysts that have covered the stock in the […]
January 2, 2024
Verastem, Inc. (NASDAQ:VSTM – Get Free Report) has received an average rating of “Buy” from the seven research firms that are presently covering the stock, MarketBeat reports. Seven investment analysts have rated the stock with a buy recommendation. The average 1 year target price among brokers that have issued a report on the stock in […]
December 11, 2023
BVF Inc. IL lowered its holdings in shares of Verastem, Inc. (NASDAQ:VSTM – Free Report) by 91.1% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,685,219 shares of the biopharmaceutical company’s stock after selling 17,337,437 shares during the period. BVF Inc. IL owned […]
December 8, 2023
Shares of Verastem, Inc. (NASDAQ:VSTM – Get Free Report) have been given a consensus recommendation of “Buy” by the seven brokerages that are currently covering the firm, MarketBeat.com reports. Seven investment analysts have rated the stock with a buy rating. The average twelve-month target price among analysts that have issued ratings on the stock in […]
November 26, 2023
Verastem (NASDAQ:VSTM – Get Free Report) and NextCure (NASDAQ:NXTC – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, institutional ownership, earnings, profitability, analyst recommendations, risk and valuation. Profitability This table compares Verastem and NextCure’s net margins, […]
November 19, 2023
Verastem (NASDAQ:VSTM – Free Report) had its price target reduced by Truist Financial from $39.00 to $34.00 in a research report released on Wednesday morning, Benzinga reports. Truist Financial currently has a buy rating on the biopharmaceutical company’s stock. A number of other analysts have also issued reports on the stock. B. Riley assumed coverage […]